BioBusiness Latest News
Minister welcomes 3millionlives approach ‘3 million lives’ will extend the reach of telehealth and telecare, to improve the lives of many people with long term conditions and social care needs Paul Burstow MP, Minister of State for Care Services re-affirmed his commitment to working with industry to improve the lives of millions of people today by publishing a Concordat with the four trade associations representing the telehealth and telecare industry. ‘3millionlives’ is about transforming service delivery for people with long term conditions, and/or social care needs, by utilising telehealth and telecare within health and social care services, enabling millions of people to receive the significant benefits evidenced in the UK’s Whole System Demonstrator trials (the largest randomised control trial of telecare and telehealth in the world).
But the benefits are not just related to the individual recipient and their families. These services are also cost-effective, and the WSD trial proved that telehealth could provide a 14% reduction in bed days and an 8% reduction in tariff costs – significant indeed with our increasingly aged population and the inevitable impact on already stretched resources. Care Services Minister Paul Burstow said: “This new approach is set to improve the quality of care for 3 million people, increase their independence and dignity as well as reduce the time they spend in hospital. It is only by the telehealth industry working together with the Department of Health and other stakeholders, that this will be possible. In addition, UK industry will gain a competitive edge in a marketplace where many millions of people worldwide could benefit from this technology, helping to generate income and jobs in the UK" |
Tip of the week!
BioBusiness success through Collaborative Networks
Dr Peter Donnelly is interviewed on the impact collaborative networking can bring industry and the importance of bringing the Academic, Business and Clinical stakeholders together. The outputs can often bring new products or services to market, or accelerate the activity companies are already pursuing. Michael Caulfield, Chief Executive of Intelesens, also illustrates how collaborative networks has supported the commercial needs of his company.
BioBusiness have been supporting many companies through its collaborative networking programmes and have provided a leverage of funding of over £1.7 million in introducing 2 new products and 3 new services to market through its “Medical Devices in Connected Health Network”, funded by Invest NI.
Dr Donnelly said that “Collaborative Networks was the area BioBusiness could bring most significant impact to support commercial activities through its All-Island, UK wide, European and US networks in bringing organisations together to accelerate the whole route to market. BioBusiness as the Network Hub provides the facilitating and brokering services necessary to enable collaborative networks to develop and utilities its Capability Building Toolkit to support companies from product concept to new global markets.”
Featured Events
| Event Date | Event and Location | Event Summary |
|---|---|---|
| Thursday, March 1, 2012 | Irish Association for Cancer Research (IACR) Annual Meeting |
Culloden Hotel Belfast |
| Thursday, May 10, 2012 | 4th Annual Translational Medicine Conference |
Inflammatory Process and Cardiovascular Disease |
| Tuesday, July 10, 2012 | Invest NI supported Trade Shows |
Africa Health 2012, HOSPITALAR 2012, FIME 2012, NICE 2012 |
Featured News
| Title | Summary |
|---|---|
| Almac’s New Clinical Supply Forecasting Tool COMPASS | To Improve Clinical Trial Management |
| HeartSine Technologies Wins 2011 MarCom Awards for New Brand Design | Newly updated marketing collateral earns Platinum and Gold MarCom Awards for creative excellence |
| Intelesens CSO recieves OBE | Professor Jim McLaughlin has been honoured in the Queen’s New Year Honours List for 2012, receiving an OBE. |
| Courses focus of prevention of heart disease | NUI Galway |
| Warner Chilcott to Present at the 30th Annual J.P. Morgan Healthcare Conference | BioBusiness Member |
| Liquid ready to use Cystatin C assay provides a more sensitive marker of GFR compared to Creatinine | The liquid ready to use Cystatin C assay from Randox provides a good indicator of Glomerular Filtration Rate GRF |
| Multi-analyte Immunoassay Control with assayed values for 54 analytes including Vitamin D | The Randox Acusera immunoassay premium plus control is designed to monitor the accuracy and precision of up to 54 analytes including 25-OH Vitamin D and 1-25(OH)2 Vitamin D |
| Major Northern Ireland presence at Arab Health including BioBusiness Members | Randox and Armstrong Medical showcase Products along with other Northern Ireland companies will be on show in the Arab Health Exhibition and Congress in Dubai |
| Minister Sherlock opens call for applications to €22 million Enterprise Ireland Technology Transfer Strengthening Initiative | Major investment to support new company creation and transfer of intellectual property between Higher Education Institutions and industry |
| Telehealth to benefit 3 Million NHS Patients | Prime Minister David Cameron |
| First Mobile Medical App to get CE Mark in UK | Airstrip |
| 4th Annual Translational Medicine Conference | REGISTER NOW |
| BioBusiness sign MOU with Belfast Metropolitan College |

